Stockscreener 앱 받기
8.71
1.59%
-0.11
Regenxbio Inc (RGNX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
76.00%
21.36
|
89.01 | 21.21 | 24.20 | 22.30 |
Operating Expenses
|
10.08%
84.64
|
76.89 | 66.26 | 73.89 | 67.75 |
| Benefits Costs and Expenses |
2.06%
84.64
|
82.93 | 72.40 | 86.28 | 78.33 |
| Costs And Expenses |
10.08%
84.64
|
76.89 | 72.58 | 86.28 | 78.33 |
| Depreciation and Amortization |
1.26%
3.905
|
3.955 | 4.023 | 3.961 | 4.051 |
| Operating Income/Loss |
621.79%
-63.28
|
12.13 | -51.37 | -62.08 | -56.04 |
| Nonoperating Income/Loss |
25.63%
-7.593
|
-6.044 | 0.182 | 2.481 | 3.048 |
| Income/Loss From Continuing Operations Before Tax |
1,140%
-63.28
|
6.083 | -51.19 | -62.08 | -56.04 |
| Income/Loss From Continuing Operations After Tax |
1,265%
-70.87
|
6.083 | -51.19 | -59.60 | -52.99 |
|
Net Income/Loss
|
1,265%
-70.87
|
6.083 | -51.19 | -59.60 | -52.99 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.24%
51.48
|
51.36 | 0.458 | 50.80 | 50.60 |
| Diluted Average Shares |
0.10%
51.48
|
51.43 | 0.458 | 50.80 | 50.60 |
| Basic Earnings Per Share |
1,250%
-1.38
|
0.12 | -1.00 | -1.17 | -1.05 |
| Diluted Earnings Per Share |
1,250%
-1.38
|
0.12 | -1.00 | -1.17 | -1.05 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.14%
0.30%
자본화:
|
볼륨(24시간):